An agreement on drug precursors - defined as the chemical substancesindispensable for manufacturing drugs - has been initialled between the European Union and the US government.
It will now be possible for both the EU and USA, which are jointly responsible for a majority of the world trade in chemicals, to share sensitive information in this area and pool their resources in stopping the diversion of chemical precursors into the illicit production of narcotic and psychotropic drugs.
For the European Commission, Mario Monti said this was the first EU-US agreement in the drug sector. It is envisaged that because of its importance, it will form a centerpiece of the EU-USA summit in Amsterdam towards the end of May.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze